Swedish Drug Co. Backs $8B Buyout Offer From Advent, GIC
Swedish drugmaker Sobi said Thursday its shareholders should accept a 69.4 billion Swedish krona ($8 billion) buyout offer from Advent International and Singapore sovereign wealth fund GIC....To view the full article, register now.
Already a subscriber? Click here to view full article